The principles of therapy for modern diagnosis of brain tumors in children, which determine the prescription of the drugs

Currently, the daily routine of a molecular pathologist is DNA methylation and RNA and DNA sequencing. The authors, from the standpoint of researchers and clinicians, explain the molecular methods used not only to diagnose brain tumors, but also to search for possible targets for therapy.

1. WHO Classification of Tumours Editorial Board. Central nervous system tumours. [Electronic resource]: https://tumourclassifi cation. iarc.who.int/chapters/45. Lyon (France): International Agency for Research on Cancer; 2021. (WHO classifi cation of tumours series, 5th ed.; vol. 6).

2. Capper D., Jones D.T.W., Sill M., Hovestadt V., Schrimpf D., Sturm D., Koelsche C., Sahm F., Chavez L., Reuss D.E., Kratz A., Wefers A.K., Huang K., Pajtler K.W., Schweizer L., Stichel D., Olar A., Engel N.W., Lindenberg K., Harter P.N., Braczynski A.K., Plate K.H., Dohmen H., Garvalov B.K., Coras R., Hölsken A., Hewer E., Bewerunge-Hudler M., Schick M., Fischer R., Beschorner R., Schittenhelm J., Staszewski O., Wani K., Varlet P., Pages M., Temming P., Lohmann D., Selt F., Witt H., Milde T., Witt O., Aronica E., Giangaspero F., Rushing E., Scheurlen W., Geisenberger C., Rodriguez F.J., Becker A., Preusser M., Haberler C., Bjerkvig R., Cryan J., Farrell M., Deckert M., Hench J., Frank S., Serrano J., Kannan K., Tsirigos A., Brü ck W., Hofer S., Brehmer S., Seiz-Rosenhagen M., Hänggi D., Hans V., Rozsnoki S., Hansford J.R., Kohlhof P., Kristensen B.W., Lechner M., Lopes B., Mawrin C., Ketter R., Kulozik A., Khatib Z., Heppner F., Koch A., Jouvet A., Keohane C., Mü hleisen H., Mueller W., Pohl U., Prinz M., Benner A., Zapatka M., Gottardo N.G., Driever P.H., Kramm C.M., Mü ller H.L., Rutkowski S., von Hoff K., Frü hwald M.C., Gnekow A., Fleischhack G., Tippelt S., Calaminus G., Monoranu C.M., Perry A., Jones C., Jacques T.S., Radlwimmer B., Gessi M., Pietsch T., Schramm J., Schackert G., Westphal M., Reifenberger G., Wesseling P., Weller M., Collins V.P., Blü mcke I., Bendszus M., Debus J., Huang A., Jabado N., Northcott P.A., Paulus W., Gajjar A., Robinson G.W., Taylor M.D., Jaunmuktane Z., Ryzhova M., Platten M., Unterberg A., Wick W., Karajannis M.A., Mittelbronn M., Acker T., Hartmann C., Aldape K., Schü ller U., Buslei R., Lichter P., Kool M., Herold-Mende C., Ellison D.W., Hasselblatt M., Snuderl M., Brandner S., Korshunov A., von Deimling A., Pfi ster S.M. DNA methylation-based classifi cation of central nervous system tumours. Nature. 2018;555(7697):469–74. doi: 10.1038/nature26000.

3. Capper D., Stichel D., Sahm F., Jones D.T.W., Schrimpf D., Sill M., Schmid S., Hovestadt V., Reuss D.E., Koelsche C., Reinhardt A., Wefers A.K., Huang K., Sievers P., Ebrahimi A., Schöler A., Teichmann D., Koch A., Hänggi D., Unterberg A., Platten M., Wick W., Witt O., Milde T., Korshunov A., Pfi ster S.M., von Deimling A. Practical implementation of DNA methylation and copynumber-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018;136(2):181–210. doi: 10.1007/s00401-018-1879-y.

4. Ryzhova M.V., Telysheva E.N., Shaikhaev E.G., Starovoitov D.V., Kotelnikova A.O., Galstyan S.A., Okonechnikov K.V. Current diagnostic methods in molecular classifi cation of brain tumors at the Burdenko Neurosurgical Center. Zhurnal Voprosy Neirokhirurgii Imeni N.N. Burdenko = Burdenko’s Journal of Neurosurgery. 2021;85(6):98–101. (In Russ.). doi: 10.17116/neiro20218506198.

5. Ryzhova M.V., Galstyan S.A., Telysheva E.N. Significance of DNA methylation assessment in the morphological diagnosis of brain tumours. Arkhiv patologii = Pathology Archive. 2022;84(3):65–75. (In Russ.). doi: 10.17116/patol20228403165.

6. Sievers P., Henneken S.C., Blume C., Sill M., Schrimpf D., Stichel D., Okonechnikov O., Reuss D.E., Benzel J., Maa K.K., Kool M., Sturm D., Zheng T., Ghasemi D.R., Kohlhof-Meinecke P., Cruz O., Suol M., Lavarino C., Ruf V., Boldt H.B., Pags M., Pouget C., Schweizer L., Kranendonk M.E.G., Akhtar N., Bunkowski S., Stadelmann C., Schü ller U., Mueller W.C., Dohmen H., Acker T., Harter P.N., Mawrin C., Beschorner R., Brandner S., Snuderl M., Abdullaev Z., Aldape K., Gilbert M.R., Armstrong T.S., Ellison D.W., Capper D., Ichimura K., Reifenberger G., Grundy R.G., Jabado N., Krskova L., Zapotocky M., Vicha A., Varlet P., Wesseling P., Rutkowski S., Korshunov A., Wick W., Pfi ster S.M., Jones D.T.W., von Deimling A., Pajtler K.W., Sahm F. Recurrent fusions in PLAGL1 defi ne a distinct subset of pediatric-type supratentorial neuroepithelial tumors. Acta Neuropathol. 2021;142:827–39. doi: 10.1007/s00401-021-02356-6.

7. Alhalabi K.T., Stichel D., Sievers P., Peterzie H., Sommerkamp A.C., Sturm D., Wittmann A., Sill M., Jager N., Beck P., Pajtler K.W., Snuder M., Jour G., Delorenzo M., Martin A.M., Levy A., Dalvi N., Hansford J.R., Gottardo N.G., Uro-Coste E., Maurage C.-A., Godfraind C., Fanny Vandenbos F., Pietsch T., Kramm C., Filippidou M., Kattamis A., Jones C., Ora I., Mikkelsen T.S., Zapotocky M., Sumerauer D., Scheie D., McCabe M., Wesseling P., Tops B.B.J., Kranendonk M.E.G., Karajannis M.A., Bouvier N., Papaemmanuil E., Dohmen H., Acker T., von Hoff K., Schmid S., Miele E., Filipski K., Kitanovski L., Krskova L., Gojo J., Haberler C., Alvaro F., Ecker J., Selt F., Milde T., Witt O., Oehme I., Kool M., von Deimling A., Korshunov A., Pfi ster S.M., Sahm F., Jones D.T.W. PATZ1 fusions defi ne a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum. Acta Neuropathol. 2021;142:841–57. doi: 10.1007/s00401-021-02354-8.

8. Roosen M., Odé Z., Bunt J., Kool M. The oncogenic fusion landscape in pediatric CNS neoplasms. Acta Neuropathol. 2022;143(4):427–51. doi: 10.1007/s00401-022-02405-8.

9. Okonechnikov K.V., Ryzhova M.V., Galstyan S.A., Telysheva E.N. Application of high throughput sequencing in pediatric neurooncology. Arkhiv patologii = Pathology Archive. 2022;84(2):58 63. (In Russ.). doi: 10.17116/patol20228402158.

10. Capper D., Reifenberger G., French P.J., Schweizer L., Weller M., Touat M., Niclou S.P., Euskirchen P., Haberler C., Hegi M.E., Brandner S., Le Rhun E., Rudà R., Sanson M., Tabatabai G., Sahm F., Wen P.Y., Wesseling P., Preusser M., van den Bent M.J. EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. Neuro Oncol. 2023;25(5):813–26. doi: 10.1093/neuonc/noad008.

11. Petrova E.I., Galstyan S.A., Telysheva E.N., Ryzhova M.V. Visualization of DNA methylation profiling data as a quality control tool for molecular classifi cation of CNS tumors. Rossiiskii neirokhirurgicheskii zhurnal imeni professora A.L. Polenova = Russian Neurosurgical Journal named after prof. A.L. Polenov. 2022;14(4):64–70. (In Russ.) doi: 10.56618/20712693_2022_14_4_64..

12. Kobiakov G.L., Absaliamova O.V., Poddubskiy A.A., Lodygina K.S., Kobyakova E.A. The 2016 WHO classifi cation of primary central nervous system tumors: a clinician’s view. Zhurnal Voprosy Neirokhirurgii Imeni N.N. Burdenko = Burdenko’s Journal of Neurosurgery. 2018;88(3):88 96. (In Russ.). doi: 10.17116/neiro201882388.

13. Dinikina Yu.V., Belogurova M.B. Major features of the 2021 WHO Classification of Tumors of the Central Nervous System: clinician’s view. Rossiyskiy zhurnal personalizirovannoy meditsiny = Russian Journal for Personalized Medicine. 2022;2(4):77–90. (In Russ.). doi: 10.18705/2782-3806-2022-2-4-77-90.